Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Mar 22;13(6):1446. doi: 10.3390/cancers13061446

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2021 by the authors.

Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

Assessment of ILC subsets in patients with disease control (DC) and in patients without disease control (w/oDC). Absolute lymphocyte counts (ALC) and absolute ILC counts per µL in DC and w/oDC patients (A). Percentages of lin⁻CD7⁺ ILC, CD56^bright, CD56^dim, and ILC1 in live PBMCs from DC and w/oDC patients (B). A Wilcoxon matched-pair signed rank test was used to compare the percentages in patients with DC between D0 and other times of treatment. A Mann–Whitney test was used to compare the percentages between DC and w/oDC patients (* p < 0.05, ** p < 0.01).